This is the authors' abstract. We don't add key points for this paper.
In Chile, a country with a GDP per capita of USD$17,000, various immunization strategies are cost-saving for scenarios comparable to pre-pandemic 2019 and to the particularly severe 2023 when considering only those direct costs associated with patient care, albeit differing in their impact in health outcomes. The resulting decrease in healthcare strain during the Winter virus surge underscores the strategy's impact.
No takes yet. Share an insight, caveat, or question.
Sauré et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: